chevron_leftBack
As of 24 April 2025, SynBiotic SE has a market cap of $24.08M USD, ranking #28810 globally and #338 in Germany. It ranks #2876 in the Healthcare sector, and #607 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$24.08MUSD
21.24M EUR
Enterprise Value
$25.91MUSD
22.86M EUR
Revenue (TTM)
$4.38MUSD
3.86M EUR
EBITDA (TTM)
-$8.55MUSD
-7.54M EUR
Net Income (TTM)
-$12.05MUSD
-10.63M EUR
EBITDA Margin
-195%
Profit Margin
-275%
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Daniel Kruse
open_in_new
Employees
55
Founded
2024
Website
synbiotic.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | 1.1% | -5% | -31% | -46% | -70% |
Upcoming Earnings
Earnings Date
Fri, May 16
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SBX
SynBiotic SE Registered Shares
ISIN: DE000A3E5A59
Shares Out.:
Shares Outstanding:
5.6M1
Shares Float:
3.061M2
|
3.13 EUR | |
|
SBX
SynBiotic SE Registered Shares
ISIN: DE000A3E5A59
|
3.11 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SynBiotic SE
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was incorporated in 2024 and is based in Munich, Germany.
